Legal Representation
Attorney
Ian W. Gillies
USPTO Deadlines
Next Deadline
2160 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20251118)
Due Date
November 18, 2031
Grace Period Ends
May 18, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
31 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 18, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Nov 18, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 28, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Oct 28, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Oct 15, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jan 16, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Apr 29, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 28, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 16, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 17, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jan 16, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 6, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jul 16, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 21, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 21, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 1, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 16, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 8, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jan 8, 2024 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jan 8, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jan 6, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 5, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 5, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 5, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Oct 5, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Jul 7, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 7, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 7, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 5, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 9, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 26, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Pharmaceutical drug discovery services; pharmaceutical research
and development; providing medical research and scientific
information in the fields of pharmaceuticals, biology, chemistry,
biochemistry, and biotechnology; consulting services in the fields of
pharmaceuticals, biology, chemistry, biochemistry, and
biotechnology; research and development of new products; providing
scientific information, scientific, pharmaceutical, and medical
research in the field of developing pharmaceutical drugs, drug
discovery and development services, and consulting services with
respect to using a photocatalyst molecule for labeling a protein
proximate to a target disease-causing protein within a live cell
First Use Anywhere:
Sep 18, 2024
First Use in Commerce:
Sep 18, 2024
Classification
International Classes
042